Abstract
Severe community-acquired pneumonia is a clinical diagnosis with significant impact on healthcare management around the world, with the highest morbidity and mortality of all the forms of community-acquired pneumonia. Severe pneumonia patients usually require intensive care unit management, including vasopressors and/or mechanical ventilation. Early clinical suspicion and prompt empiric antimicrobial therapies are mandatory in patients with severe pneumonia. A number of recent studies and guidelines addressing these issues have been published. They are reviewed in this article.
Keywords
Intensive Care Unit Admission Severe Acute Respiratory Syndrome Acute Respiratory Failure Respir Crit Severe Acute Respiratory Syndrome
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- 1.Pneumonia and influenza death rates: United States, 1994. Morb Mortal Wkly Rep 1995; 44: 535–7.Google Scholar
- 2.National Center for Health Statistics, Centers for Disease Control and Prevention: Advance report of final mortality statistics 1992. Hyattsville, MD: U.S. Department of Health and Human Services, Public Health Service, 1994.Google Scholar
- 3.Marston BJ, Plouffe JF, File TM Jr., et al., for the Community-Based Pneumonia Incidence Study Group. Incidence of community-acquired pneumonia requiring hospitalization: Results of a population-based active surveillance study in Ohio. Arch Intern Med 1997; 157: 1709–18.PubMedCrossRefGoogle Scholar
- 4.Roson B, Carratala J, Dorca J, et al. Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis 2001; 33: 158–65.PubMedCrossRefGoogle Scholar
- 5.Niederman MS, Mandell LA, Anzueto A, et al. American Thoracic Society: Guidelines for the management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730–54.PubMedGoogle Scholar
- 6.European Study on Community-Acquired Pneumonia (ESOCAP) Committee. Guidelines for management of adult community-acquired lower respiratory tract infections. Eur Respir J 1998; 11: 986–91.CrossRefGoogle Scholar
- 7.Huchon, G, Woodhead M. Management of adult community-acquired lower respiratory tract infections. Eur Respir Rev 1998; 8: 391–426.Google Scholar
- 8.Mandell LA, Marrie TJ, Grossman RF, et al. Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000; 31: 383–421.PubMedCrossRefGoogle Scholar
- 9.Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000; 31: 347–82.PubMedCrossRefGoogle Scholar
- 10.Heffelfinger JD, Dowell SF, Jorgensen JH, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance. Arch Intern Med 2000; 160: 1399–1408.PubMedCrossRefGoogle Scholar
- 11.Dean NC, Suchyta MR, Bateman KA, et al. Implementation of admission decision support for community-acquired pneumonia. Chest 2000; 117: 1368–77.PubMedCrossRefGoogle Scholar
- 12.Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243–50.PubMedCrossRefGoogle Scholar
- 13.Marrie TJ, Lau CY, Wheeler SL, et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. JAMA 2000; 283: 749–55.PubMedCrossRefGoogle Scholar
- 14.Ewig S, Schafer H, Torres A: Severity assessment in community-acquired pneumonia. Eur Respir J 2000; 16: 1193–201.PubMedCrossRefGoogle Scholar
- 15.Ewig S, Ruiz M, Mensa J, et al. Severe community-acquired pneumonia: Assessment of severity criteria. Am J Respir Crit Care Med 1998; 158: 1102–08.PubMedGoogle Scholar
- 16.The British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br J Hosp Med 1993;49:346–50.Google Scholar
- 17.Cordero E, Pachon J, Rivero A, et al. Community-acquired bacterial pneumonia in human immunodeficiency virus-infected patients: Validation of severity criteria. The Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. Am J Respir Crit Care Med 2000; 162: 2063–8.PubMedGoogle Scholar
- 18.Pascual FE, Matthay MA, Bacchetti P, et al. Assessment of prognosis in patients with community-acquired pneumonia who require mechanical ventilation. Chest 2000; 117: 503–12.PubMedCrossRefGoogle Scholar
- 19.Garcia-Ordonez MA, Garcia-Jimenez JM, Paez F, et al. Clinical aspects and prognostic factors in elderly patients hospitalised for community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 2001; 20: 14–9.PubMedGoogle Scholar
- 20.El-Solh AA, Sikka P, Ramadan F, et al. Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med 2001; 163: 645–51.PubMedGoogle Scholar
- 21.Afessa B, Green B. Bacterial pneumonia in hospitalized patients with HIV infection: The Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. Chest 2000; 117: 1017–22.PubMedCrossRefGoogle Scholar
- 22.Luna CM, Famiglietti A, Absi R, et al. Community-acquired pneumonia: Etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest 2000; 118: 1344–54.PubMedCrossRefGoogle Scholar
- 23.Meehan TP, Chua-Reyes JM, Tate J, et al. Process of care performance, patient characteristics, and outcomes in elderly patients hospitalized with community-acquired or nursing home-acquired pneumonia. Chest 2000; 117: 1378–85.PubMedCrossRefGoogle Scholar
- 24.Chien JW, Johnson JL. Viral pneumonias. Epidemic respiratory viruses. Postgrad Med 2000;107:41–2, 45–7, 51–2.Google Scholar
- 25.Ramos MM, Overturf GD, Crowley MR. Infection with sin nombre hantavirus: Clinical presentation and outcome in children and adolescents. Pediatrics 2001; 108: E27.PubMedCrossRefGoogle Scholar
- 26.Lim WS, Macfarlane JT, Boswell TC, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: Implications for management guidelines. Thorax 2001; 56: 296–301.PubMedCrossRefGoogle Scholar
- 27.Birch C, Gowardman J. Streptococcus pyogenes: A forgotten cause of severe community-acquired pneumonia. Anaesth Intensive Care 2000; 28: 87–90.PubMedGoogle Scholar
- 28.CDC. Update: outbreak of severe acute respiratory syndrome worldwide, 2003. MMWR 2003; 52: 241–8.Google Scholar
- 29.World Health Organization. Cumulative number of reported cases of severe acute respiratory syndrome (SARS). http://www.who.int/csr/sarscountry/2003.
- 30.Peiris JSM, Lai ST, Poon LLM, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet, 2003, in press.Google Scholar
- 31.Poutamen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003; 348: 1995–2005.CrossRefGoogle Scholar
- 32.Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348: 1986–1994.PubMedCrossRefGoogle Scholar
- 33.Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348: 1977–85.PubMedCrossRefGoogle Scholar
- 34.Leroy O, Santre C, Beuscart C. A 5-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an ICU. Intensive Care Med 1995; 21: 24–31.PubMedCrossRefGoogle Scholar
- 35.Moine P, Vercken JB, Chevret S, et al. Severe community-acquired pneumonia: Etiology, epidemiology, and prognosis factors. Chest 1994; 105: 1487–95.PubMedCrossRefGoogle Scholar
- 36.Tones A, Serra-Battles J, Ferrer A, et al. Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis 1991; 144: 312–18.CrossRefGoogle Scholar
- 37.Manie TJ. Community-acquired pneumonia in the elderly. Clin Infect Dis 2000; 31: 106678.Google Scholar
- 38.Moroney JF, Fiore AE, Harrison LH, et al. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis 2001; 33: 797–805.PubMedCrossRefGoogle Scholar
- 39.Kahn M, Ortqvist A, Almela M, et al. Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis 2000; 182: 840–7.CrossRefGoogle Scholar
- 40.Metlay JP, Hofmann J, Cetron MS, et al. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2000; 30: 520–8.PubMedCrossRefGoogle Scholar
- 41.Mehta R, Groth M. Clinical application of a prognostic model for severe community-acquired pneumonia. Chest 2001; 119: 312–3.PubMedCrossRefGoogle Scholar
- 42.Waterer GW, Somes GW, Wunderink RG. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 2001; 161: 1837–42.PubMedCrossRefGoogle Scholar
- 43.Burgess DS, Lewis JS II. Effect of macrolides as part of initial empiric therapy on medical outcomes for hospitalized patients with community-acquired pneumonia. Clin Ther 2000; 22: 872–8.PubMedCrossRefGoogle Scholar
- 44.Gleason PP, Meehan TP, Fine JM, et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999; 159: 2562–72.PubMedCrossRefGoogle Scholar
- 45.Martinez JA, Horcajada JP, Almela M. et al. Addition of a macrolide to a ß-lactambased empirical antibiotic regimen is associatred with lower mortality for patients with bacteremic pnuemococcal pneumonia. Clin Infect Dis 2003; 36: 389–95.PubMedCrossRefGoogle Scholar
- 46.Dresser LD, Niederman MS, Paladino JA. Cost-effectiveness of gatifloxacin versus ceftriaxone with a macrolide for the treatment of community-acquired pneumonia. Chest 2001; 119: 1439–48.PubMedCrossRefGoogle Scholar
- 47.Halley HJ. Approaches to drug therapy, formulary, and pathway management in a large community hospital. Am J Health Syst Pharm 2000; 57 (Suppl 3): S17–21.PubMedGoogle Scholar
- 48.Yost NP, Bloom SL, Richey SD, et al. An appraisal of treatment guidelines for antepartum community-acquiredpneumonia. Am J Obstet Gynecol 2000; 183: 131–5.PubMedGoogle Scholar
- 49.Palmer CS, Zhan C, Elixhauser A, et al. Economic assessment of the community-acquired pneumonia intervention trial employing levofloxacin. Clin Ther 2000; 22: 250–64.PubMedCrossRefGoogle Scholar
- 50.Fogarty CM, Greenberg RN, Dunbar L, et al. Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: Integrated results from 4 open-label, multicenter, phase III clinical trials. Clin Ther 2001; 23: 425–39.PubMedCrossRefGoogle Scholar
- 51.Clark LC, Davis CW. Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia. Am J Health Syst Pharm 2000; 57 (Suppl 3): S10–3.PubMedGoogle Scholar
- 52.Arancibia F, Ewig S, Martinez JA, et al. Antimicrobial treatment failures in patients with community-acquired pneumonia: Causes and prognostic implications. Am J Respir Crit Care Med 2000; 162: 1540.Google Scholar
- 53.Eron LJ, Passos S. Early discharge of infected patients through appropriate antibiotic use. Arch Intern Med 2001; 161: 61–5.PubMedCrossRefGoogle Scholar
- 54.Ramirez JA, Bordon J. Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia. Arch Intern Med 2001; 161: 848–50.PubMedCrossRefGoogle Scholar
- 55.Rhew DC, Tu GS, Ofman J, et al. Early switch and early discharge strategies in patients with community-acquired pneumonia: A meta-analysis. Arch Intern Med 2001; 161: 722–7.PubMedCrossRefGoogle Scholar
- 56.Wunderink R, Leeper K Jr, Schein R, et al. Filgrastim in patients with pneumonia and severe sepsis or septic shock. Chest 2001; 119: 523–9.PubMedCrossRefGoogle Scholar
- 57.Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699–709.PubMedCrossRefGoogle Scholar
- 58.Tobin MJ. Advances in mechanical ventilation. N Engl J Med 2001; 344: 1986–96.PubMedCrossRefGoogle Scholar
- 59.Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 13349.CrossRefGoogle Scholar
- 60.The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301–8.Google Scholar
- 61.Confalonieri M, Potena A, Carbone G, et al. Acute respiratory failure in patients with severe community-acquired pneumonia. Am J Respir Crit Care Med 1999; 160: 158591.Google Scholar
- 62.Navalesi P, Pollini A. Acute respiratory failure in patients with severe community-acquired pneumonia: A prospective, randomized evaluation of noninvasive ventilation. Am J Respir Crit Care Med 2000; 162: 761–2.PubMedGoogle Scholar
- 63.Jolliet P, Abajo B, Pasquina P, et al. Noninvasive pressure support ventilation in severe community-acquired pneumonia. Intensive Care Med 2001; 27: 812–21.PubMedCrossRefGoogle Scholar
- 64.Hilbert G, Gruson D, Vargas F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344: 481–7.PubMedCrossRefGoogle Scholar
- 65.Meduri GU, Turner RE, Abou-Sala N, et al. Noninvasive positive pressure ventilation via face mask. First-line intervention in patients with acute hypercapnic and hypoxemic respiratory failure. Chest 1996; 109: 179–93.PubMedCrossRefGoogle Scholar
- 66.Conti G, Marino P, Cogliati A, et al. Noninvasive ventilation for the treatment of acute respiratory failure in patients with hematologic malignancies: A pilot study. Intensive Care Med 1998; 24: 1283–8.PubMedCrossRefGoogle Scholar
- 67.Antonelli M, Conti G, Bufi M, et al. Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: A randomized trial. JAMA 2000; 283: 235–41.PubMedCrossRefGoogle Scholar
Copyright information
© Springer Science+Business Media New York 2004